Pharming Group N.V. (PHAR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pharming Group N.V.

    NASDAQ: PHAR · Real-Time Price · USD
    14.90
    -0.36 (-2.36%)
    At close: Sep 08, 2025, 3:50 PM
    14.98
    0.54%
    After-hours: Sep 08, 2025, 04:10 PM EDT

    Pharming Income Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 297.2M 245.32M 205.62M 189.85M
    Cost of Revenue
    		 35.4M 25.21M 17.56M 20.18M
    Gross Profit
    		 261.8M 220.1M 188.06M 169.67M
    Operating Income
    		 -8.62M -4.88M 18.23M 27.84M
    Interest Income
    		 5.72M 3.53M 85.05K 52.92K
    Pretax Income
    		 -8.2M -12.01M 14.99M 22.03M
    Net Income
    		 -10.64M -10.55M 13.67M 16M
    Selling & General & Admin
    		 99.22M 87.5M 131.82M 92.05M
    Research & Development
    		 83.15M 68.91M 52.53M 67.18M
    Other Expenses
    		 88.06M 69.08M -14.52M -2.5M
    Operating Expenses
    		 270.42M 225.49M 169.83M 156.72M
    Interest Expense
    		 8.74M 5.96M 5.47M 6.18M
    Selling & Marketing Expenses
    		 7.13M 6.82M 85.8M 56.75M
    Cost & Expenses
    		 305.82M 250.7M 187.39M 176.91M
    Income Tax Expense
    		 2.43M -1.46M 1.31M 6.76M
    Shares Outstanding (Basic)
    		 68.92M 65.7M 88.39M 87.64M
    Shares Outstanding (Diluted)
    		 68.92M 65.7M 88.39M 87.64M
    EPS (Basic)
    		 -0.15 -0.14 0.17 0.20
    EPS (Diluted)
    		 -0.15 -0.14 0.15 0.18
    EBITDA
    		 16.32M 9.88M 33.53M 48.78M
    EBIT
    		 245K -6.05M 20.34M 29.17M
    Depreciation & Amortization
    		 16.07M 15.93M 13.19M 19.61M

    Add to Watchlist